Background: Biopesticides based on strains of the bacteriumBacillus thuringiensis(Bt) are used globally for effective and environmentally friendly pest control. The most serious threat to the sustainable use of these microbial pesticides is the development of resistance on targeted pests. Populations ofPlutella xylostella(diamondback moth) have evolved field resistance to Bt pesticides at diverse locations worldwide. Discovery of novel Bt strains with varied toxin profiles that overcome resistance is one of the strategies to increase sustainability of Bt pesticides againstP. xylostella. In this study, we report isolation and characterization of a Bt strain named AB1 from Sri Lanka displaying toxicity towards larvae ofP. xylostellaresistant to the commercial Bt pesticide Dipel.Methods: Strains of Bt from diverse environments in Sri Lanka were evaluated for protein crystal production through Differential Interference Contrast (DIC) microscopic examination, and for insecticidal activity againstP. xylostellain bioassays. The genome of the AB1 strain was sequenced by Hiseq Illumina sequencing to identify the insecticidal genes present in the genome and nano liquid chromatography followed by tandem mass spectrometry (nanoLC/MS/MS) of purified crystal proteins of AB1 was performed to identify the expressed insecticidal proteins. Multilocus sequence typing andGyrase Bgene sequence analyses were performed to identify the phylogenetic origin of the AB1 strain.Results: The AB1 strain was identified as producing high levels of bipyramidal crystals and displaying insecticidal activity against susceptible and Dipel-resistant strains ofP. xylostella. Multilocus sequence typing and phylogenetic analysis of theGyrase Bgene identified that AB1 belongs to theB. thuringiensissubsp.aizawaiserotype.Comparative analysis of genomic and proteomic data showed that among the insecticidal protein coding genes annotated from the AB1 genome (cry1Aa,cry1Ca,cry1Da,cry1Ia,cry2Ab andcry9), Cry1Ca and Cry1Da toxins represented most of the toxin fraction in parasporal crystals from AB1. Overall findings warrant further development ofB. thuringiensissubsp.aizawaiAB1 strain as a pesticide to controlP. xylostella.
Alzheimer’s disease (AD) causes progressive cognitive decline and neuronal loss, partly due to the buildup of amyloid-β (Aβ) plaques and tau tangles. Despite years of research, treatments targeting these hallmark pathologies have yielded only modest clinical success, prompting interest in regenerative approaches to restore the brain’s ability to repair itself. One such approach focuses on adult hippocampal neurogenesis, the process by which neural stem cells (NSCs) produce new neurons throughout life. In AD, this process is impaired, worsening cognitive deficits. In this review, we examine the molecular pathways that control adult neurogenesis, including transcriptional, epigenetic, inflammatory, and metabolic mechanisms, and how they become dysregulated in AD. We also highlight various therapeutic strategies aimed at boosting neurogenesis, such as pharmacological treatments, stem cell therapy, gene therapy, and epigenetic modulation. Preclinical studies indicate that enhancing neurogenesis can improve cognition and reduce brain pathology in AD models. Several of these treatments are now being tested in clinical trials. Ultimately, promoting neurogenesis may offer a promising avenue to complement current AD therapies and help restore lost neural function.
The Fanconi anemia (FA) protein FANCD2, and MCM8/9 heterohexameric helicase complex are critical for maintaining genomic integrity in response to replication stress. However, the nature of their relationship remains unclear. Here, we show that MCM8/9 physically interacts and functionally cooperates with FANCD2 during the repair of DNA interstrand crosslinks (ICLs). Using immunofluorescence and co-immunoprecipitation studies, we show that MCM8/9 interacts with FANCD2 through its core domain, independently of DNA. FANCD2 is essential for the recruitment of MCM9 to ICL damage induced nuclear foci and acts downstream the FANCD2I monoubiquitination. Although MCM8/9 foci formation requires its intact ATPase activity, BRCv motif and HROB, these are not required for FANCD2 binding, highlighting a distinction between physical interaction and functional activation. Interestingly, FANCD2 foci formation increase in MCM8 or MCM9 knockout cells, suggesting that MCM8/9 functions to mitigate replication associate stress. γH2AX DNA damage assays and cell survival assays show that combined loss of MCM9 and FANCD2 do not cause any additive DNA damage beyond individual knockouts, indicating an epistatic relationship and suggests they function in the same DNA repair pathway. Together, our findings identify MCM8/9 as a downstream effector of the FA pathway critical for resolving ICL induced DNA damage. Highlights: MCM8/9 interacts and colocalize with FANCD2 upon ICL DNA damage. FANCD2 is essential for recruitment of MCM9 to DNA damage site. MCM8/9 is epistatic to FANCD2 and within the same DNA damage response pathway.